Pill combo offers new hope for rural head and neck cancer patients

NCT ID NCT06997068

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether taking three oral chemotherapy drugs together is safe and practical for patients with head and neck cancer that has returned or spread. The trial focuses on people living in rural Midwest areas, making it easier for them to participate from home. The goal is to see if this approach can control the disease and improve access to treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carcinoma head and neck cancer Head and Neck Neoplasms hypopharyngeal carcinoma hypopharynx cancer laryngeal carcinoma laryngeal neoplasm larynx cancer lip and oral cavity carcinoma lip and oral cavity squamous cell carcinoma Mouth Neoplasms oral cavity cancer oral cavity carcinoma oropharyngeal carcinoma oropharynx cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic in Rochester

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact